Cargando…

Efficacy and tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders

Detalles Bibliográficos
Autor principal:	Andrade, Chittaranjan
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2004
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951661/ https://www.ncbi.nlm.nih.gov/pubmed/21224917

Ejemplares similares

Efficacy and Tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Chavda, R.K., et al.
Publicado: (2004)

Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder
por: Basu, Ranita, et al.
Publicado: (2006)

Dose-Dependent Efficacy of Aripiprazole in Treating Patients With Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Qian, Li, et al.
Publicado: (2021)

Clinical Usefulness of Aripiprazole and Lamotrigine in Schizoaffective Presentation of Tuberous Sclerosis
por: Lee, Seung-Yup, et al.
Publicado: (2016)

Augmentation of Clozapine with Aripiprazole in Severe Psychotic Bipolar and Schizoaffective Disorders: A Pilot Study
por: Benedetti, Alessandra, et al.
Publicado: (2010)

Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder
por: Archibald, Luke, et al.
Publicado: (2019)

Efficacy and Safety of Aripiprazole for Treatment of Irritability in Children with Autistic Disorder: An Open-Label Study
por: Habibi, Nastaran, et al.
Publicado: (2015)

Measuring Emotional Awareness in Patients With Schizophrenia and Schizoaffective Disorders
por: Maaßen, Eva, et al.
Publicado: (2021)

Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder
por: Mathalon, Daniel H., et al.
Publicado: (2010)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting
por: Hsieh, Ming-Hong, et al.
Publicado: (2010)

Trauma and Posttraumatic Stress Disorder (PTSD) in Patients with Schizophrenia or Schizoaffective Disorder
por: Lommen, Miriam J. J., et al.
Publicado: (2009)

Cardiovascular Risk for Patients With and Without Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder
por: Rossom, Rebecca C., et al.
Publicado: (2022)

Religious Coping Strategies for Religious Patients with Schizophrenia and Schizoaffective Disorder
por: Gedevani, E., et al.
Publicado: (2022)

The use of technologies and social media in patients with schizophrenia and schizoaffective disorder
por: Elleuch, O., et al.
Publicado: (2022)

Clinical factors affecting functioning in patients with schizophrenia or schizoaffective disorder
por: Neily, C., et al.
Publicado: (2022)

Aripiprazole cardiosafety: Is it overestimated?
por: Naguy, Ahmed
Publicado: (2016)

Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder
por: Stauffer, Virginia L, et al.
Publicado: (2010)

The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Ko, Young-Hoon, et al.
Publicado: (2014)

Study of the Effect of Memantine on Negative Sign in Patients with Schizophrenia and Schizoaffective Disorders
por: Tavakoli-Ardakani, Maria, et al.
Publicado: (2018)

Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
por: Kesserwani, Jad, et al.
Publicado: (2019)

Social and Neurocognitive Deficits in Remitted Patients with Schizophrenia, Schizoaffective and Bipolar Disorder
por: Dehelean, Liana, et al.
Publicado: (2021)

INTOLERANCE TO NOISE IN PSYCHIATRIC DISORDERS
por: Andrade, Chittaranjan
Publicado: (2000)

Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder
por: Amann, B. L., et al.
Publicado: (2015)

Impairment in delay discounting in schizophrenia and schizoaffective disorder but not primary mood disorders
por: Brown, Hannah E., et al.
Publicado: (2018)

Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder
por: Hammer, C, et al.
Publicado: (2014)

Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
por: Fagiolini, Andrea
Publicado: (2010)

The continuing story of schizophrenia and schizoaffective disorder: One condition or two?
por: Hartman, Leah I., et al.
Publicado: (2019)

PREDICTION OF ANTIDEPRESSANT EFFICACY FROM RESPONSE TO THE FIRST ECT
por: Andrade, Chittaranjan
Publicado: (1998)

Novel use of granulocyte colony stimulating factor as an adjunct for treatment of schizoaffective disorder complicated by sodium valproate induced agranulocytosis
por: Subbarayan, S., et al.
Publicado: (2012)

SUBSYNDROMAL SYMPTOMS IN BIPOLAR DISORDER : ROLE OF LITHIUM
por: Andrade, Chittaranjan, et al.
Publicado: (2003)

A case of delusional parasitosis presented as shared psychotic disorder treated successfully with aripiprazole
por: Canlı, Derya
Publicado: (2020)

Social function in schizophrenia and schizoaffective disorder: Associations with personality, symptoms and neurocognition
por: Lysaker, Paul H, et al.
Publicado: (2004)

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder
por: Perkins, Diana O, et al.
Publicado: (2007)

Blonanserin-induced Mood Alteration in Schizophrenia and Schizoaffective Disorder: Two Cases
por: Min, Aran, et al.
Publicado: (2013)

Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder
por: Arion, Dominique, et al.
Publicado: (2015)

Evidence for Distinguishable Treatment Costs among Paranoid Schizophrenia and Schizoaffective Disorder
por: Hirjak, Dusan, et al.
Publicado: (2016)

Aripiprazole for olanzapine-induced symptomatic hyper prolactinemia
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Wisconsin card sorting test performance impairment in schizophrenia: Flaws in a report
por: Parekh, Pravesh, et al.
Publicado: (2018)

Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders
por: Pinna, Federica, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ucop96ih9v1b0r14an7i11ilag